Earlier quoted context omitted.
Don't some insurers outright deny cover for chronic or genetic conditions?
In the US, medical insurers are not allowed to deny coverage for chronic or genetic conditions due to the Genetic information Nondiscrimination Act of 2008 (GINA) and the Affordable Care Act of 2010 (Obamacare). Some treatments may require proof of medical necessity, or require that providers and patients try lower cost options first (step therapy). Rules for life insurers are different and in some circumstances they…
First UK child to receive gene therapy for fatal genetic disorder is now healthy
121–130 of 199 posts
Re: First UK child to receive gene therapy for fatal genetic disorder is now healthy
#122Thats a new stealth weapon for the global population to watch out for now, knowing how things work in this country.
Re: First UK child to receive gene therapy for fatal genetic disorder is now healthy
#123Re: First UK child to receive gene therapy for fatal genetic disorder is now healthy
#124Re: First UK child to receive gene therapy for fatal genetic disorder is now healthy
#125Thats a new stealth weapon for the global population to watch out for now, knowing how things work in this country.
Re: First UK child to receive gene therapy for fatal genetic disorder is now healthy
#126I wonder if a similar approach can be used for Von Hippel Landau. “ Mutations in the VHL gene cause von Hippel-Lindau syndrome. The VHL gene is a tumor suppressor gene, which means it keeps cells from growing and dividing too rapidly or in an uncontrolled way. Mutations in this gene prevent production of the VHL protein or lead to the production of an abnormal version of the protein. An altered or missing VHL protein…
Re: First UK child to receive gene therapy for fatal genetic disorder is now healthy
#127> Teddi and her sister Nala, age 3, were both diagnosed with MLD in April 2022, according to the NHS. Unfortunately, Nala was not eligible for Libmeldy because she'd already developed symptoms of the disorder. Holy shit. My god, I'm just thinking of the parents. "Sorry, we can only save one of your kids." "You can't give Nala the treatment?" "Well, we could . We won't, though." I'm sure there are good reasons, but Je…
Does that mean clincal trials didn't show a benefit for patients who had already developed symptoms? Does it mean it wasn't studied in patients who had already developed symptoms?
I don't think it's unreasonable that the NHS won't spend large amounts of other people's money on a treatment that hasn't been studied or wasn't found to be effective.
Re: First UK child to receive gene therapy for fatal genetic disorder is now healthy
#128https://en.m.wikipedia.org/wiki/Atidarsagene_autotemcel > The National Centre for Pharmacoeconomics (NCPE) in Ireland recommends "that atidarsagene autotemcel not be considered for reimbursement unless cost effectiveness can be improved relative to existing treatment." Wow… instead of a lifesaving cure they recommend the treatment of the symptoms until the kid dies because it’s cheaper .
You have X amount of dollars. You can spend Y percent on healthcare. How do you spend Y to have the greatest benefit? Save 1 patients with a $300,000 gene therapy, or save 1,000 patients with effective treatment for their diabetes.
Until we have unlimited resources, that trade off will always be made.
Re: First UK child to receive gene therapy for fatal genetic disorder is now healthy
#129Earlier quoted context omitted.
What sort of regulation? Make it cheaper by x% per year or we stop using it? Doesn't sound that dissimilar to "make it cheaper than the total cost of the current treatment or we won't use it".
I’d just change the “or we won’t use it” to “or your patents go away.”
"Hey, that's a nice life-saving treatment you spent $500M developing. It would be a shame if we just took it from you."
Re: First UK child to receive gene therapy for fatal genetic disorder is now healthy
#130Earlier quoted context omitted.
Another country where nationalized healthcare is a bad idea.
Not sure I follow. It's not like a therapy with a sticker price of $3.8 million is more available in countries without nationalized healthcare.
Look at the Blue Cross Blue Shield plan for Michigan. It covers a number of gene therapies at a cost of $2.2M for one of them.
Not all European countries pay for it.
https://www.bcbsm.com/amslibs/content/dam/public/employers/d...